ArticleEndocrine connections2025
Point-of-care ionised calcium testing: lab validation and clinical feasibility study.
Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients undergoing thyroid and parathyroid surgery require frequent assessment of blood calcium levels to guide their management, and currently such measurements are performed mostly in hospital environments on main laboratory platforms. The aim of this study was to explore the potential use of a non-medical LAQUA device designed to measure ionised calcium in environmental samples as a pocket-size point-of-care device able to measure blood calcium concentration in patients after thyroid and parathyroid surgery. Methods: The protocol of the study consisted of three distinctive phases: surveying the technological landscape and identifying currently available devices and technologies able to measure calcium in a small volume of whole blood easily, quickly, and accurately (Phase 1); testing the potential candidate device in a laboratory (Phase 2); and performing a prospective, single-arm study (IRAS ID 236079, Protocol number 18/0058, REC ref 19/LO/1740), during which simultaneous calcium measurements were performed on venous and capillary blood on LAQUA and 'gold standard' platforms Roche Cobas-Calcium-Gen.2 and Blood Gas Analyser ABL90 (Phase 3). Results: In Phase 1, LAQUA (HORIBA Inc. Japan) was identified as the most promising potential POC device in terms of size, simplicity of use, and cost effectiveness. In Phase 2, LAQUA showed good accuracy (Δmean = 0.09; P = 0.33) and precision (CV 3.41%) in measuring ionised calcium in standardised solutions. In Phase 3, 30 patients were recruited and had 67 sets of measurements. 'Gold standard' venous adjusted calcium (Roche) and ionised calcium (BGA) were equivalent, R = 0.95, (P < 0.001). Strong positive correlation R = 0.75 (P = <0.001) was observed between venous ionised calcium measured on BGA and LAQUA. Positive but weaker correlation was found between venous (BGA) and capillary (LAQUA) ionised calcium R = 0.68, (P = <0.001), and between venous and capillary ionised calcium (LAQUA), R = 0.56 (P = <0.001). Conclusions: LAQUA is a promising device, which can measure ionised calcium accurately in small venous but not yet capillary blood samples. Further device development is needed before it can be recommended as a potential POC device to measure calcium in blood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.